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We investigated the presence of factors in human milkthat inhibit Invasion of pathogenic bacteria. The efl'ect 
of human milk fat globule membrane (HMFGM) components on adhesion of cloned S-fimbriated Escherichia 
coli to human buccal epithelial cells was analyzed. S fimbriae are a common feature of E. coli strains causing 
sepsis and meningitis in newborns and are bound to epithelia via sialyl-(a-2-3)galactoside structures. Human 
milk fat globules (HMFG) could be agglutinated by the above-mentioned bacteria. Agglutination could be 
inhibited by fetuin, human glycophorin, and a 1-acid glycoprotein. In addition, pretreatment of HMFG with 
Jlibrio cholerae neuraminidase markedly reduced bacterium-induced agglutinations, indicating the involve-
ment of neuraminic acid-containing glycoproteins. In contrast, Iipid droplets of infant formula or artificiallipid 
emulsions (Intralipid) could not be agglutinated. HMFG were present in stools of breast-fed neonates as shown 
by indirect immunofluorescence staining with a monoclonal antibody directed against carbohydrate residues 
present on HMFGM. These HMFG could be agglutinated by bacteria. HMFG inhibited E. coli adhesion to 
buccal epithelial cells. To further characterize relevant E. coli binding structures, HMFGM components w~re 
separated by gel chromatography. The mucin fraction showed the most pronounced inhibitory efrect on 
adhesion of S-fimbriated E. coli to human buccal epithelial cells. Our data soggest that HMFG inhibit bacterial 
adhesion in the entire intestine and thereby may provide protection against bacterial infection. 
Human milk provides protection against different types of 
infections (9). This protective function is based on a complex 
immunologic system. The importance of immunoglobulins, 
predominantly secretory immunoglobulin A and other fac-
tors such as Iysozyme, lactoferrin, the lactoperoxidase sys-
tem, and cellular components (macrophages, lymphocytes) 
has been assessed. Further protective properties can be 
ascribed to nonimmunoglobulin components such as gly-
colipids, glycoproteins, and free oligosaccharides that are 
capable of inhibiting bacterial adhesion to epithelia, thus 
preventing bacterial infection at the stage of bacterial colo-
nization (1, 2, 14, 20). 
Adhesion of bacteria to target cells is usually mediated by 
well-defined glycoproteins on bacterial fimbriae (5, 21, 27). 
S-fimbriated Escherichia coli organisms used in our studies 
are of major importance in newborns as pathogens causing 
sepsis and meningitis (23). Adhesins, lectinlike molecules of 
S fimbriae, recognize receptor structures present in a variety 
of membrane glycoproteins expressing NeuAc a-2-3 resi-
dues (17, 28, 33). 
Milk fat in human milk is concentrated in globules with 
diameters of 1 to 10 IJ.ffi (29, 35). The membrane surrounding 
the Iipid core is derived from the apical plasma membrane of 
mammary epithelial cells by apocrine secretion (11, 12). 
High-molecular-mass glycoproteins with a high content of 
0-glycosidic-linked carbohydrates (termed mucins) are a 
major constituent of these membranes (7, 13, 41). As these 
human milk fat globule membranes (HMFGM) are of epithe-
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lial origin, we expected them to express carbohydrate struc-
tures that might serve as receptor analogs for certain patho-
genic bacteria. For porcine milk fat globule membranes, 
binding of porcine enteropathogenic K88-positive E. coli and 
inhibition of guinea pig hemagglutination by K88-positive E. 
coli has been described previously (3, 4). 
Therefore, we addressed two major questions: (i) can 
human milk fat globules (HMFG) inhibit binding of S-fimbri-
ated E. coli to epithelial cells, and (ii) what are the relevant 
membrane components mediating inhibition of bacterial ad-
hesion? 
MATERIALS AND MEmODS 
Bacteria. Adhesion experiments were carried out with E. 
coli HB101 with the recombinant plasmid (pANN 801-4) 
which encodes S fimbriae (17). In controls, E. coli HB101 
organisms without plasmid and therefore without S fimbriae 
were used. Only in a few preliminary experiments, because 
of the instability of S fimbria expression in vitro, strain IH 
3084 (kindly provided by T. Korhonen, University of Hel-
sinki, Helsinki, Finland), which was isolated from a patient 
with neonatal meningitis and which also carries S fimbriae, 
was used. Bacteria were grown on NB agar (Difco Labora-
tories, Detroit, Mich.) supplemented with 0.1% glucose and 
tetracycline (30 IJ.g/ml). After an 18-h incubation period at 
37°C, bacteria were harvested with ice-cold 20 mM sodium 
borate buffer, pH 9.0, and washed twice with the same 
buffer. Following adjustment to 1010 bacteria per ml, 1 ml of 
the suspension was Iabelied with 100 ...,g of ftuorescein 
isothiocyanate (FITC) (Sigma Chemical Co., St. Louis, 
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MO.) with constant shaking for 30 min at 23°C. To remove 
excess FITC, the reaction mixture was Jayered on top of 4 ml 
of phosphate-buffered saline (PBS) containing 6% (wt/vol) 
bovine serum albumin (BSA) and centrifuged (15 min, 1,500 
x g). The pellet containing Iabeiied bacteria was washed 
once or twice with PBS ( containing 0.1% BSA and 0.5% 
methyl-a-o-mannoside ), pH 7 .4, until the supernatant was 
clear (32). 
Isolation of buccal epithelial cells. Buccal epithelial cells 
were obtained from healthy adult nonsmokers by scraping 
buccal mucosa with a spoon-shaped spatula several times. 
Cells were washed off the spatula with PBS, washed three 
more times, and were microscopically adjusted to 105 cells 
per ml. 
Binding of bacteria to buccal epithelial cells and preincuba-
tion ofbacteria with inhibitors. Bacteria in buffer (2 x 108/ml) 
or the bacterium-inhibitor mixture was added to 250 ._.,t of 
epithelial cell suspension (ratio of cells to bacteria, 1:1,000) 
and incubated for 60 min in a shaking ice bath. Epithelial 
cells were washed three tim es with PBS ( centrifugation for 5 
min at 4°C and 120 x g) before microscopic evaluation. 
For inhibition studies, 125 ..._t of the bacterial suspension (2 
x lOH bacteria per ml) was incubated with 125 ._.,1 of one of 
the following inhibitors for 15 min in an ice bath: human 
glycophorin (HGP) (1 mglml), a 1-acid glycoprotein (10 mg/ 
ml), fetuin (5 mglml), HMFG, HMFGM fractions (1 mglml), 
asialo-HGP (1 and 8 mglml), and NeuAc (1 to 20 mglml, 
adjusted to pH 7.4). By using the viable count technique, it 
was shown that inhibitors did not influence the bacteria's 
viability. All chemieals were obtained from Sigma. 
In order to better define receptor structure, 2 x 105 
epithelial cells were treated with Vibrio cholerae neuramin-
idase (1 U/ml; Behring, Marburg, Germany) for 1 h at 37°C 
and washed twice with PBS. The number of bacteria binding 
to the cell surface was analyzed by ftuorescence microscopy. 
Fifty epithelial cells were analyzed for each experiment. All 
experiments were done in duplicate. 
Isolation of milk fat globules from human colostrum and 
stools of breast-fed infants. Fifty milliliters of fresh milk 
collected on the fourth day of Iactation was used for agglu-
tination experiments. The milk was centrifuged at 1,000 x g 
at room temp~rature for 30 min to obtain cream. The cream 
was washed four times in 10 volumes of sucrose-PBS (0.25 
M sucrose, to which was added 10% PBS, pH 7.4). HMFG 
in sucrose-PBS were used at a concentration 20 times higher 
than the concentration resulting in an optical density of 1.8 at 
605 nm. Freshly obtained cow's milk was treated in an 
identical manner. For control experiments, an adapted infant 
formula (Pre-Aptamil; Milupa) and Intralipid 20% (Kabi 
Vitrum, Stockholm, Sweden) were used, the latter as a 
control for artificial phospholipid membranes. Stools of five 
breast-fed and five formula-fed infants (day 4) as weil as the 
ileostomy secretions of a 10-day-old breast-fed infant with 
intestinal atresia were mixed with 4 volumes of sucrose-PBS 
and centrifuged in the same manner as milk. The Iipid layer 
on top was taken off and washed six times with sucrose-PBS. 
Major particles were removed mechanically between centrif-
ugation steps. 
Demonstration of HMFG in stools of breast-fed infants. 
Fifty microliters of the washed Iipid fraction isolated from 
stools of breast-fed and formula-fed newborns was added to 
a 1:50,000 dilution of ascitic fluid containing monoclonal 
antibody directed against HMFGM, 115 G 3 (kindly pro-
vided by J. Hilkens, University of Amsterdam, Amsterdam, 
The Netherlands). The antibody recognizes the carbohy-
drate structure Galß-1-3[Fuca-1-4]-GlcNAcß-1-3-Galß-1-4-
INFECf. IMMUN. 
[Fuca-1-3]-GlcNAcß (Lewis3 and Lewisx sequence) (15). 
The mixture of antibody and Iipid fraction was incubated for 
10 min in an ice bath with gentle shaking. Cross-reaction has 
been shown for mucins in various body ftuids. Excess 
antibody was removed by washing before 20 .... 1 of a phyco-
erythrin-labelled goat anti-mouse antibody (Southern Bio-
technology Associates, Birmingham, Ala.) diluted 1:10 in 
PBS was added. Following another incubation period of 10 
min at 4°C in the dark, 200 ._.,t of sucrose-PBS was added for 
ftuorescence microscopy. Nonspecific mouse immunoglob-
ulin (Sigma) was used in a control experiment instead of the 
monoclonal antibody. 
Preparation of HMFGM. Freshly secreted human breast 
milk (first 14 days of lactation) was obtained from volun-
teers, pooled, and defatted by centrifugation at 3,000 x g for 
1 h at 4°C. The cream was washed several times in 5 volumes 
of 0.01 M Tris HCI, pH 7 .2, by centrifugation under the same 
conditions. Washed cream from appfoximately 3 Iiters of 
human milk was suspended in a total volume of 500 ml of 
0.01 M Tris HCI, pH 7.2, and kept in the cold (4°C) for 1 h. 
The suspension was then allowed to reach room temperature 
while it was shaken on a Iabaratory shaker until butter 
formed. The process of membrane release was completed by 
incubation of the mixture at 40°C for 30 min. The membranes 
were recovered as a yellow pellet after centrifugation at 
35,000 x g (30 min) and washed twice with water prior to 
freeze-drying. 
Agglutination of HMFG and HMFGM by bacteria. Agglu-
tinations of HMFG from colostrum and stools and Iipid 
droplets from infant formula and Intralipid suspended as 
described above were analyzed after mixture of 1 drop of 
suspension with 1 drop of bacterial (E. co/i HB101 [pANN 
801-4) and E. coli IH 3084) Suspension (5 x 109/ml) on a glass 
slide at 4°C and room temperature with gentle shaking. 
Sonicated HMFGM were treated in an analogaus manner. In 
control experiments, bacteria without plasmid were used. 
In inhibition experiments, 20 ...,1 of bacterial suspension 
was mixed with 20 ._.,t of putative inhibitor at different 
concentrations for 15 min at 4°C. NeuAc served as a 
monovalent control, and asialo-HGP served as a polyvalent 
control. Agglutination intensity was .read macroscopically 
and microscopically. To determine the roJe of NeuAc in 
HMFG residues responsible for bacterial binding, 40 ._.,t of 
HMFG was incubated with 1 ml of V. cholerae neuramini-
dase (1 U/ml) at 37°C, washed, and then added to the 
bacteria. 
Isolation and immunochemical characterization of HMFGM 
mucin. Solubilization of the membrane proteins and fraction-
ation according to their sizes were performed as described 
by Shimizu and Yamauchi (41). Fractions HMFG-A to 
HMFG-D (see Fig. 2) were dialyzed against waterat 4°C, 
freeze-dried, and delipidated by extraction with cold meth-
anol-chloroform (1/2, vol/vol). 
HMFG-A was immunochemically identified as the poly-
morphic epithelial mucin-containing fraction after chemical 
deglycosylation with triftuoromethanesulfonic acid accord-
ing to the method of Hakimuddin and Bahl (18). Binding of 
monoclonal antibody SM-3 defining the peptide sequence 
Pro-Asp-Thr-Arg-Pro (6) was analyzed in a double-sandwich 
solid-phase enzyme immunoassay by using anti-mouse im-
munoglobulin (Z 259; Dako, Hamburg, Germany) and anti-
alkaline phosphatase-alkaline phosphatase complex detec-
tion. 
Isolation and purification of S fimbriae. S fimbriae were 
isolated essentially according to the procedure described by 
Salit and Gotschlich (37) as modified by Wevers et al. (43). 
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T ABLE 1. Inhibition of bacterial adhesion (E. coli HB101 
(pANN 801-4]) to human buccal epithelial cellsa 
Inhibitor Concn Inhibition of (mg/ml) adhesionh (%) 
a 1-Acid glycoproteinc 10 43 ± 11 
Fetuinc 5 42 ± 7 
HGpc 1 49 ± 12 
Asialo-HGP 1 9±4 
Asialo-HGP 8 28 ± 6 
NeuAc 1-20 1 ± 2 
a Specificity of bacterial adhesion has been confirmed in control experi-
ments by neuraminidase treatment of buccal epithelial cells. 
h Means ± Standard deviations for tive experi!llents. 
c Inhibitors were used at concentrations of 1 to 20 mg/ml, and values 
corresponding to approximately 50% are given. The actual decrease of 
adhesion in percent is presented if 50% inhibition could not be reached. 
The puritY of the preparation was eonfirrned by sodium 
dodecyl sulfate (SDS)-polyaerylamide gel eleetrophoresis 
and examination by eleetron mieroseopy. 
Electrophoresis and binding of fimbriae to transblots. Gly-
eoprotein samples (1 mg preineubated ·in 100 J.Ll of sample 
buffer eontaining 0.3% SDS and 3% 2-mereaptoethanol for 
10 min at 90°C) were separated on polyaerylamide gels (7 .5% 
or 3 to 13%) in the presenee of SOS (0.1%) at 40 mA. Gels 
were fixed and stained with Coomassie blue or periodie acid 
Sehiff's (PAS) reagent. Eleetroblotting onto nitroeellulose 
(0.45 J.Lm) was perforrned at 200 mA in Tris (25 mM)-glycine 
(192 mM)-methanol (20% ). 
The nitroeellulose sheets were immersed in PBS, pH 7.2, 
eontaining 5% (wt/vol) BSA to bloek residual surfaee aetiv-
ity and overlaid with a solution of Ieetin peroxidase eonju-
gate diluted in 0.5% BSA-PBS (5 to 10 J,Lg/ml). As leetins, 
peroxidase-labelled Ieetins from Triticum vulgaris (WGA) 
and from Arachis hypogeae (PNA) were used. After ineuba-
tion for 1 h at room temperature and three sueeessive 
washing steps (0.5% BSA-PBS), the membranes were devel-
oped in PBS-methanol (17% [vol/vol]) containing 1-ehloro-
4-naphthol (0.055%) and hydrogen peroxide (0.008% ). Max-
imum staining was obtained after 30 min in the dark. For 
binding of purified fimbriae, membranes were overlaid for 17 
h with fimbriae suspended in PBS (125 J,Lg of protein per ml) 
or with fimbriae and HGP (1 mglml) at 4°C. 
For immunostaining, membranes were ineubated for 1 h at 
4°C with monoclonal antibody A 21356 Al (1:1,000), whieh 
recognizes S fimbriae (28) (kindly provided by K. Jann). 
Alkaline phosphatase-conjugated anti-mouse immunoglobu-
lin (1:1,000) (Dako) was added for 30 min at room tempera-
ture and washed four times with PBS. Membranes were 
developed with 5-bromo-4-ehloro-3-indoxyl-phosphate (Na2 
salt) and Nitro Blue Tetrazolium ehloride (Serva, Heidel-
berg, Germany) for 15 min at 37°C. 
RESULTS 
Adhesion of S-fimbriated E. co/i to human buccal cells. 
Fluoreseenee mieroseopy of bueeal epithelial eells after 
ineubation with FITC-labelled S-fimbriated E. coli showed 
that 75 to 95% of epithelial eells from 10 different donors had 
bound baeteria. On average, 1,103 (±293) baeteria had 
bound to 50 eells. Charaeteristies of binding of the clinieal 
isolate IH 3084 to bueeal epithelial eells did not differ from 
those for the cloned strain HB101 (pANN 801-4) (data not 
shown). The abilities of human glyeophorin, fetuin, and 
a 1-acid glyeoprotein to inhibit binding were markedly differ-
FIG. 1. (a) Demonstration of HMFG in stool of a breast-fed 
newborn by indirect immunofluorescence with monoclonal antibody 
115 G 3. Magnification, x600. (b) Stool of a formula-fed newborn 
prepared as described for panel a. 
ent. For quantitative eomparison of the effieacy of inhibition, 
eoneentrations resulting in approximately 50% inhibition 
were eompared with eaeh other (Table 1). lf inhibitionwas 
less than 50%, individual values are given. NeuAe as a 
monovalent eontrol showed no inhibition; asialo-HGP as a 
polyvalent eontrol substanee was slightly able to inhibit 
binding. Pretreatment of epithelial eells with neuraminidase 
markedly redueed the number of binding bacteria to 27% of 
the eontrol, indicating the relevanee of NeuAc for binding of 
S fimbriae. 
Agglutination of HMFG and HMFGM by bacteria. HMFG 
isolated from eolostrum were agglutinated by S-fimbriated E. 
coli HB101 (pANN 801-4) and IH 3084 after 10 min, as 
shown macroscopically and microscopically ( data not 
shown). HB101 without plasmid failed to agglutinate 
HMFG. Raising the temperature from 4°C to room temper-
ature markedly aeeelerated the reaetion. This agglutination 
was probably due to speeifie interaction of bacteria with 
HMFGM beeause isolated membranes could also be aggre-
gated (data not shown). 
By using FITC-labelled monoclonal antibody (115 G 3) 
direeted against HMFGM (15), undigested HMFG eould be 
demonstrated in both normal stools of breast-fed infants and 
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FIG. 2. Sepharose CL-4B column chromatography of membrane proteins from HMFG. Gel exclusion chromatography of extracted 
membranes was performed on a Sepharose CL-4B column (1.5 by 60 cm), equilibrated, and run in 15 mM Tris-HCI buffer (pH 8.0) containing 
100 01M NaCl and 10 mM sodium deoxycholate (ftow rate, 6 ml!h). The eluatewas monitared at 280 nm and pooled in subfractions HMFG-A 
to HMFG-D as indicated. Fractions HMFG-A arid HMFG-B contain the majority of HMFGM mucins (41). 
intestinal fluid from one breast-fed infant with ileostomy. In 
contrast, stools of formula-fed infants were devoid of HMFG 
(Fig. 1a and b ). 
Nonspecific mouse immunoglobulin G did not react with 
HMFG. Globules isolated from stools could still be aggluti-
nated by bacteria. Agglutination was not altered in slightly 
acidic conditions (stool of breast-fed infants, pH 5). In 
contrast, Iipid droplets isolated from adapted infant formula 
or Intralipid showed no reactions with bacteria either mac-
roscopically or microscopically. Milk fat globules isolated 
from fresh cow's milk reacted, but the agglutination was 
weaker compared with that of HMFG. 
Pretreatment of HMFG with neuraminidase almost com-
pletely abrogated agglutinability. Agglutination could be 
inhibited with concentrations of inhibitors identical to those 
used in the buccal epithelial cell binding assay. Inhibition by 
all effective inhibitorswas dose dependent from 0.15 to 20 
mg/ml. 
Inhibition of bacterial adhesion by HMFG and HMFGM 
fractions. Membranes prepared from milk fat globules of 
approximately 3 Iiters of human breast milk yielded 1 g of 
freeze-dried HMFGM. The solubilized membrane compo-
nents were separated according to their size on a Sepharose 
CL-4B column into four major fractions corresponding to 
mucins (HMFG-A + B), sialoglycoproteins (HMFG-C), and 
glycolipids and phospholipids (HMFG-D) (41) (Fig. 2). The 
different fractions (HMFG-A to HMFG-D) obtained from 
column chromatography had extensively been characterized 
previously by Shimizu and Yamauchi (HMFG-A to HMFG-D 
corresponding to fractions F1 to F4 in their study) (41). 
Patterns of SDS-polyacrylamide gel electrophoresis ob-
tained from HMFG and their Chromatographie subfractions 
are shown in Fig. 3. Staining with Coomassie blue revealed 
a series of 10 major bands, most of which were PAS-reactive 
glycoproteins. The prominent mucin band at the top of the 
gel was found exclusively in fractions HMFG-A and -B, 
which appeared to be homogenaus on the basis of 
Coomassie blue and PAS staining. A Western blot (immu-
noblot) analysis of HMFGM glycoproteins by staining with 
WGA or PNA revealed strong binding activity by the HM 
FGM mucin for both lectins, while the membrane glycopro-
teins were stained only moderately or not at all (Fig. 3). The 
presence of PNA-reactive Thomsen-Friedenreich antigen 
(Galß-1-3-GalNAc) on HMFGM mucin is a characteristic 
feature of this membrane component from lactating mam-
mary epithelia (13). A high sialic acid content of the HM-
FGM mucin is indicated by its strong binding capacity for 
WGA on Western blots (41). In addition, polymorphic epi-
thelial mucin was identified in fraction HMFG-A by using 
monoclonal antibody SM-3 (data not shown). 
HMFG-A and -B contain the mucins, but fraction A is 
regarded to be contaminated by other proteins responsible 
for the strong absorption at 280 nm. The pure mucin in 
fraction B does not absorb at 280 nm because of its Iack of 
aromatic amino acids. Accordingly, there is no relationship 
between antiadhesive effects and the protein profile regis-
tered at 280 nm. 
HMFG and isolated fractions HMFG-A to -C were then 
functionally analyzed for the capacity to inhibit adhesion of 
our E. coli strain to buccal epithelial cells. The observed 
inhibition effects of HMFG (inhibition of adhesion, 46 to 
55%) are probably due to a competition of HMFG versus 
buccal epithelial cells on a cellular Ievel. On the other band, 
in addition to reversible competition, irreversible entrap-
ment of bacteria by HFMG agglutination is likely to contrib-
ute to the antiadhesive effect. 
The strongest inhibitory effect of HMFGM fractions (55%) 
was located in mucin-containing fractions HMFG-A and 
HMFG-B (Table 2). The efficiency of inhibition by fraction 
HMFG-A + B was comparable to that of HGP. Equal con-
centrations of HMFG-C sialoglycoproteins bad a markedly 
less pronounced inhibitory effect (18% inhibition). 
Western blot analysis of HMFGM glycoproteins by immu-
nostaining of bound S fimbriae revealed strong binding 
activity by high-molecular-mass glycoproteins of HMFGM 
(Fig. 4). Binding of fimbriae was inhibited by the receptor 
analog HGP (Fig. 4). The glycoproteins were positive on 
PAS and WGA staining and negative on Coomassie blue 
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FIG. 3. Polyacrylamide gel electrophoresis and Western blot analysis of HMFOM proteins. Membraneproteins were separated in a 7.5% 
polyacrylamide gel in the presence of 0.1% SOS and stained with Coomassie blue (lanes 1 and 2) or PAS (lanes 3 and 4). Lanes: 1 and 3, 
HMFGM; 2 and 4, Sepharose CL-4B subfraction HMFG-A; 5 and 6, Western blots of HMFGM proteins stained with WGA (lane 5) or PNA 
(lane 6). The following proteins we used for calibration: ß-galactosidase (118 kDa), BSA (67 kDa), ovalbumin (43 kDa), and horse myoglobin 
(17.8 kDa). Mr, molecular mass. 
staining (data not shown). These high-molecular-mass gly-
coproteins should be regarded as mucins on the basis of 
several lines of evidence. The binding active components in 
Western blots are characterized by their molecular masses, 
which are higher than 200 kDa; a high carbohydrate content 
as demonstrated by staining with PAS and. WGA; and, 
finally, by cochromatography with polymorphic epithelial 
mucin from human skim milk (Fig. 4). 
DISCUSSION 
In the present study, the ability of milk fat globules or 
membrane fractions to inhibit adhesion of S-fimbriated E. 
coli to epithelial cells has been analyzed. The most mean-
ingful test system to study antiadhesive properlies of milk fat 
TABLE 2. Inhibition of bacterial adhesion (E. coli HB101 
[pANN 801-4}) to human buccal epithelial cells 
Inhibitor Concn Inhibition of (mg/ml) adhesion" (%) 
HMFG _b 55 ± 3 
HMFG c 46 ± 13 
HMFG-A+B 55 ± 6 
HMFG-C 18 ± 14 
" Means :!: standard deviations for five experiments. 
" One hundred twenty-five microliters of HMFG suspension corresponding 
to 7.5 I-L8 of HMFGM containing 2.5 I-L8 of Lowry protein. 
c Sixty-three microliters of HMFG suspension corresponding to 3.8 I-L8 of 
Lowry protein_ 
globules present in stools is to use intestinal epithelia from 
newborns. Viable intestinal epithelia are difficult to obtain, 
and human intestinal cell lines as a putative alternative 
undergo morphological change with passage in tissue culture 
(10). 
Although adhesive properlies of a given bacteriaJ strain 
vary depending on the tissues used (42), we utilized buccal 
epithelial cells for two reasons: first, oral epithelia are an 
easily accessible part of the gastrointestinal tract, and, 
second, the oropharynx together with the intestine serves as 
a natural entry route for invasive pathogenic E. coli (16, 39). 
Adhesion of S-fimbriated E. coli to buccal epithelial cells is, 
like that of type I fimbriae carrying E. coli, age independent 
(8, 40). Therefore, we used epithelial cells from adults as a 
model of bacterial adhesion. 
The concept of bacterial adherence to milk fat globules has 
already been introduced in a variety of veterinary publica-
tions with reports of studies using E. coli K99 and K88 (3, 4, 
25, 36). Our studies show that these observations may be 
relevant for humans since pathogenic E. coli bind to HMFG 
and cause their agglutination. Agglutination was specifical~y 
inhibited by soluble receptor analogs (fetuin and HGP) or 
treatment of HMFG with neuraminidase. This indicates a 
majorroJe of Ne'-'Ac-containing glycoproteins as receptors 
for S-fimbriated bacteria. Lipid droplets derived from 
adapted infant formula or an intravenous fat emulsion are 
not surrounded by biomembranes and do not bind bacteria. 
The role of mucins in the prevention of bacterial adhesion 
to epithelial tissues has been documented in recent studies 
(12, 26, 38). Up to 200 carbohydrate chains are known to be 
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FIG. 4. Binding of isolated S fimbriae to immobilized glycopro-
teins on Western blots. Membraneproteins were separated on a 3 to 
13% polyacrylamide gel in the presence of0.1% SOS. Western blots 
of HMFGM proteins (lanes 1 and 2) and mucin isolated from human 
skim milk (lane 3) were stained immunochemically after being 
overlaid with purified S fimbriae as described in Materials and 
Methods. Skim milk mucin, which was available from previous 
work (19), was identified as the polymorphic epithelial mucin after 
chemical deglycosylation and immunochemical staining with mono-
clonal antibody SM-3. Lanes: 1, 0.5 mg of HMFG membranes 
overlaid with S fimbriae; 2, 0.5 mg of HMFG membranes overlaid 
with S fimbriae in the presence of HGP (1 mg/ml); 3, 100 ~g of mucin 
isolated from human skim milk, overlaid with S fimbriae. 
0-glycosidically linked to the peptide core of a mucin 
monomer exhibiting a high degree of structural diversity. 
According to this particular property, mucins which are 
found in human secretions or in epithelial membranes are 
suitable candidates for representing organ-characteristic gly-
cosylation and thus express a variety of receptor-analog 
structures for bacterial adhesins. Mucinsareregular constit-
uents of human milk serum (19) and HMFGM (13). The 
common structural unit of all acidic glycans on secretory 
milk mucins is the terminal disaccharide unit NeuAca-(2-3)-
Galß, which has been demonstrated to form a receptor 
analog for S-fimbriated E. coli (22). 
The proteelive potential of membrane sialoglycoproteins 
and mucin on the milk fat globule against bacterial infections 
has not been demonstrated so far. But it is strongly sug-
gested by the reported findings, in particular by the sialic 
acid-mediated binding of S-fimbriated E. coli to HMFGM 
and by the ability of HMFG and the isolated membrane 
mucins (fraction HMFG-A + B), to inhibit adhesion of these 
bacteria to buccal epithelial cells. 
Recently, it has been reported that milk fat globule mucins 
in receptor binding assays have inhibitory activity (31) 
against human immunodeficiency virus and rotavirus (30). 
INFEcr. IMMUN. 
HMFGM obviously express a !arge surface capable of 
binding S-fimbriated E. coli and thus decrease binding of 
bacteria to epithelial surfaces. As both buccal epithelia and 
gut epithelia are possible target cells for S-fimbriated E. coli, 
the resulting protective effect may be important for the entire 
intestine since HMFG isolated from ileostomy and stools are 
still agglutinable by bacteria. This is in accordance with 
published data indicating the excretion of up to 10% of the 
orally administered fat in stools of newborns due to relative 
exocrine pancreas insufficiency and low excretion of bile 
acids (24). 
On the other hand, it is unlikely that the whole amount of 
excreted fat is present in milk fat globules: conjugated bile 
salts at concentrations present in digests of term newborns 
and prematurely born infants are able to break up milk fat 
globules and release their membranes (34 ). 
The question of whether bacterial binding capacity of 
HMFG and HMFGM in digestsarerelevant in vivo in the 
intestine remains tobe answered. Moreover, the number of 
bacteria necessary to induce intestinal or extraintestinal 
infections in newborns is not known. 
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